Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SSY
3176
DELISTED
SunLink Health Systems
SSY
| $159K | ﹤0.01% |
139,200
+2,500
| +2% | +$2.94K |
|
3177
The ONE Group
STKS
$55.9M
| $157K | ﹤0.01% |
51,200
-19,700
| -28% | -$58.9K |
|
|
ATXS
3178
DELISTED
Astria Therapeutics
ATXS
| $156K | ﹤0.01% |
5,953
-1,609
| -21% | -$60.9K |
|
3179
SiNtx Technologies
SINT
$9.6M
| $156K | ﹤0.01% |
1
| – | – |
|
3180
Soligenix
SNGX
$5.36M
| $156K | ﹤0.01% |
756
+338
| +81% | +$95.2K |
|
|
SVBI
3181
DELISTED
Severn Bancorp Inc/MD
SVBI
| $155K | ﹤0.01% |
19,400
-8,200
| -30% | -$70.3K |
|
|
AFMD
3182
DELISTED
Affimed
AFMD
| $153K | ﹤0.01% |
4,907
-1,043
| -18% | -$38.8K |
|
|
RGLS
3183
DELISTED
Regulus Therapeutics
RGLS
| $149K | ﹤0.01% |
16,007
+11,044
| +223% | +$183K |
|
|
JP
3184
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
| $149K | ﹤0.01% |
33,900
-191,000
| -85% | -$1.38M |
|
3185
Ocugen
OCGN
$403M
| $145K | ﹤0.01% |
27,374
+21,107
| +337% | +$673K |
|
|
AVGR
3186
DELISTED
Avinger, Inc. Common Stock
AVGR
| $143K | ﹤0.01% |
159
+118
| +288% | +$196K |
|
|
NOVN
3187
DELISTED
Novan, Inc. Common Stock
NOVN
| $142K | ﹤0.01% |
17,104
+8,134
| +91% | +$166K |
|
3188
Destination XL Group
DXLG
$32.9M
| $141K | ﹤0.01% |
65,000
+48,600
| +296% | +$130K |
|
3189
Danaos Corp
DAC
$2.52B
| $140K | ﹤0.01% |
13,339
-6,970
| -34% | -$100K |
|
3190
Euroseas
ESEA
$536M
| $140K | ﹤0.01% |
30,685
+14,309
| +87% | +$115K |
|
3191
Fortress Biotech
FBIO
$111M
| $140K | ﹤0.01% |
10,850
-14,365
| -57% | -$240K |
|
|
SNCR
3192
DELISTED
Synchronoss Technologies
SNCR
| $140K | ﹤0.01% |
+2,532
| New | +$139K |
|
|
ACCS
3193
ACCESS Newswire
ACCS
$26.4M
| $140K | ﹤0.01% |
12,300
-9,373
| -43% | -$119K |
|
|
CBL
3194
DELISTED
CBL& Associates Properties, Inc.
CBL
| $137K | ﹤0.01% |
+71,300
| New | +$209K |
|
3195
Sonoma Pharmaceuticals
SNOA
$5.26M
| $134K | ﹤0.01% |
1,046
+357
| +52% | +$71.2K |
|
3196
Ovid Therapeutics
OVID
$427M
| $133K | ﹤0.01% |
+55,100
| New | +$251K |
|
3197
SCYNEXIS
SCYX
$37.4M
| $130K | ﹤0.01% |
3,378
+2,816
| +501% | +$191K |
|
|
ABAC
3198
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
| $130K | ﹤0.01% |
149,817
+6,600
| +5% | +$10.2K |
|
3199
Better Online Solutions
BOSC
$31.7M
| $129K | ﹤0.01% |
59,329
-21,663
| -27% | -$48.4K |
|
3200
China Pharma Holdings
CPHI
$48.6M
| $129K | ﹤0.01% |
1,001
+19
| +2% | +$2.76K |
|
Similar funds
Renaissance Technologies's Q4 2018 Portfolio in Review
As of Q4 2018, Renaissance Technologies held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Renaissance Technologies's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Renaissance Technologies's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Renaissance Technologies fully exited Danaher in Q4 2018, selling an estimated $350M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Renaissance Technologies opened 522 new positions and closed 504 in Q4 2018.
- Renaissance Technologies's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.